Noninvasive detection of Helicobacter pylori infection in clinical practice

The 13C urea breath test

Peter D. Klein, Hoda M. Malaty, Robert F. Martin, Kathleen S. Graham, Robert M. Genta, David Y. Graham

Research output: Contribution to journalArticle

164 Citations (Scopus)

Abstract

Objectives: To validate the 13C urea breath test for the detection of Helicobacter pylori infection both before and after treatment. Methods: 13C urea breath tests with 125-mg and 250-mg doses were carried out on each of 60 infected and 60 noninfected subjects. Results were compared with histological examination of gastric biopsies to establish detection limits. The best cut-off point was used in a clinical trial of the efficacy of the breath test in duodenal ulcer patients before and after antimicrobial therapy. The incremental increase (percentage, δ over baseline in U of δ/mil) in respiratory 13CO2 abundance was associated with histological evidence of H.pylori. Outpatient, tertiary care medical center, and secondary and primary care facilities were included. One hundred twenty healthy asymptomatic subjects and 465 patients with duodenal ulcer disease were studied. The test kit assessed repeatability of breath sample collection and storage and stability of stored samples. Test performance was analyzed by comparison of 125-mg and 250-mg C urea with measurements at 30 and 40 min postdose. The test was used to diagnose active H. pylori infection and gauge success of antimicrobial therapy. Results: The test kit results were highly reproducible. The cut-off values were higher with 250-mg compared with 125-mg doses of 13C urea and 40 min compared with 30 min. Using a 125-mg 13C urea and test detection limit of 2.4% at 30 min, the accuracy was 94.8 (95% confidence interval = 92-97%) before antimicrobial therapy and 95.4% (95% confidence interval = 91-98%) after. An increase of 2.4% in the abundance of breath 13CO2 measured 30 min after a 125-mg dose of 13C urea reliably indicated the presence of active H. pylori infection either before or after antimicrobial therapy. The 13C urea breath test provides a simple and reliable and noninvasive method of assessing H. pylori status.

Original languageEnglish (US)
Pages (from-to)690-694
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume91
Issue number4
StatePublished - Apr 1996

Fingerprint

Breath Tests
Helicobacter Infections
Helicobacter pylori
Urea
Duodenal Ulcer
Limit of Detection
Secondary Care Centers
Confidence Intervals
Duodenal Diseases
Therapeutics
Pylorus
Ambulatory Care
Tertiary Care Centers
Primary Health Care
Stomach
Healthy Volunteers
Clinical Trials
Biopsy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Klein, P. D., Malaty, H. M., Martin, R. F., Graham, K. S., Genta, R. M., & Graham, D. Y. (1996). Noninvasive detection of Helicobacter pylori infection in clinical practice: The 13C urea breath test. American Journal of Gastroenterology, 91(4), 690-694.

Noninvasive detection of Helicobacter pylori infection in clinical practice : The 13C urea breath test. / Klein, Peter D.; Malaty, Hoda M.; Martin, Robert F.; Graham, Kathleen S.; Genta, Robert M.; Graham, David Y.

In: American Journal of Gastroenterology, Vol. 91, No. 4, 04.1996, p. 690-694.

Research output: Contribution to journalArticle

Klein, PD, Malaty, HM, Martin, RF, Graham, KS, Genta, RM & Graham, DY 1996, 'Noninvasive detection of Helicobacter pylori infection in clinical practice: The 13C urea breath test', American Journal of Gastroenterology, vol. 91, no. 4, pp. 690-694.
Klein, Peter D. ; Malaty, Hoda M. ; Martin, Robert F. ; Graham, Kathleen S. ; Genta, Robert M. ; Graham, David Y. / Noninvasive detection of Helicobacter pylori infection in clinical practice : The 13C urea breath test. In: American Journal of Gastroenterology. 1996 ; Vol. 91, No. 4. pp. 690-694.
@article{a822becf28c7464a96108fefeed5fc11,
title = "Noninvasive detection of Helicobacter pylori infection in clinical practice: The 13C urea breath test",
abstract = "Objectives: To validate the 13C urea breath test for the detection of Helicobacter pylori infection both before and after treatment. Methods: 13C urea breath tests with 125-mg and 250-mg doses were carried out on each of 60 infected and 60 noninfected subjects. Results were compared with histological examination of gastric biopsies to establish detection limits. The best cut-off point was used in a clinical trial of the efficacy of the breath test in duodenal ulcer patients before and after antimicrobial therapy. The incremental increase (percentage, δ over baseline in U of δ/mil) in respiratory 13CO2 abundance was associated with histological evidence of H.pylori. Outpatient, tertiary care medical center, and secondary and primary care facilities were included. One hundred twenty healthy asymptomatic subjects and 465 patients with duodenal ulcer disease were studied. The test kit assessed repeatability of breath sample collection and storage and stability of stored samples. Test performance was analyzed by comparison of 125-mg and 250-mg C urea with measurements at 30 and 40 min postdose. The test was used to diagnose active H. pylori infection and gauge success of antimicrobial therapy. Results: The test kit results were highly reproducible. The cut-off values were higher with 250-mg compared with 125-mg doses of 13C urea and 40 min compared with 30 min. Using a 125-mg 13C urea and test detection limit of 2.4{\%} at 30 min, the accuracy was 94.8 (95{\%} confidence interval = 92-97{\%}) before antimicrobial therapy and 95.4{\%} (95{\%} confidence interval = 91-98{\%}) after. An increase of 2.4{\%} in the abundance of breath 13CO2 measured 30 min after a 125-mg dose of 13C urea reliably indicated the presence of active H. pylori infection either before or after antimicrobial therapy. The 13C urea breath test provides a simple and reliable and noninvasive method of assessing H. pylori status.",
author = "Klein, {Peter D.} and Malaty, {Hoda M.} and Martin, {Robert F.} and Graham, {Kathleen S.} and Genta, {Robert M.} and Graham, {David Y.}",
year = "1996",
month = "4",
language = "English (US)",
volume = "91",
pages = "690--694",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Noninvasive detection of Helicobacter pylori infection in clinical practice

T2 - The 13C urea breath test

AU - Klein, Peter D.

AU - Malaty, Hoda M.

AU - Martin, Robert F.

AU - Graham, Kathleen S.

AU - Genta, Robert M.

AU - Graham, David Y.

PY - 1996/4

Y1 - 1996/4

N2 - Objectives: To validate the 13C urea breath test for the detection of Helicobacter pylori infection both before and after treatment. Methods: 13C urea breath tests with 125-mg and 250-mg doses were carried out on each of 60 infected and 60 noninfected subjects. Results were compared with histological examination of gastric biopsies to establish detection limits. The best cut-off point was used in a clinical trial of the efficacy of the breath test in duodenal ulcer patients before and after antimicrobial therapy. The incremental increase (percentage, δ over baseline in U of δ/mil) in respiratory 13CO2 abundance was associated with histological evidence of H.pylori. Outpatient, tertiary care medical center, and secondary and primary care facilities were included. One hundred twenty healthy asymptomatic subjects and 465 patients with duodenal ulcer disease were studied. The test kit assessed repeatability of breath sample collection and storage and stability of stored samples. Test performance was analyzed by comparison of 125-mg and 250-mg C urea with measurements at 30 and 40 min postdose. The test was used to diagnose active H. pylori infection and gauge success of antimicrobial therapy. Results: The test kit results were highly reproducible. The cut-off values were higher with 250-mg compared with 125-mg doses of 13C urea and 40 min compared with 30 min. Using a 125-mg 13C urea and test detection limit of 2.4% at 30 min, the accuracy was 94.8 (95% confidence interval = 92-97%) before antimicrobial therapy and 95.4% (95% confidence interval = 91-98%) after. An increase of 2.4% in the abundance of breath 13CO2 measured 30 min after a 125-mg dose of 13C urea reliably indicated the presence of active H. pylori infection either before or after antimicrobial therapy. The 13C urea breath test provides a simple and reliable and noninvasive method of assessing H. pylori status.

AB - Objectives: To validate the 13C urea breath test for the detection of Helicobacter pylori infection both before and after treatment. Methods: 13C urea breath tests with 125-mg and 250-mg doses were carried out on each of 60 infected and 60 noninfected subjects. Results were compared with histological examination of gastric biopsies to establish detection limits. The best cut-off point was used in a clinical trial of the efficacy of the breath test in duodenal ulcer patients before and after antimicrobial therapy. The incremental increase (percentage, δ over baseline in U of δ/mil) in respiratory 13CO2 abundance was associated with histological evidence of H.pylori. Outpatient, tertiary care medical center, and secondary and primary care facilities were included. One hundred twenty healthy asymptomatic subjects and 465 patients with duodenal ulcer disease were studied. The test kit assessed repeatability of breath sample collection and storage and stability of stored samples. Test performance was analyzed by comparison of 125-mg and 250-mg C urea with measurements at 30 and 40 min postdose. The test was used to diagnose active H. pylori infection and gauge success of antimicrobial therapy. Results: The test kit results were highly reproducible. The cut-off values were higher with 250-mg compared with 125-mg doses of 13C urea and 40 min compared with 30 min. Using a 125-mg 13C urea and test detection limit of 2.4% at 30 min, the accuracy was 94.8 (95% confidence interval = 92-97%) before antimicrobial therapy and 95.4% (95% confidence interval = 91-98%) after. An increase of 2.4% in the abundance of breath 13CO2 measured 30 min after a 125-mg dose of 13C urea reliably indicated the presence of active H. pylori infection either before or after antimicrobial therapy. The 13C urea breath test provides a simple and reliable and noninvasive method of assessing H. pylori status.

UR - http://www.scopus.com/inward/record.url?scp=0029872421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029872421&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 690

EP - 694

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 4

ER -